CSL to replace Bavarian Nordic in Valneva's vaccine deal for Germany
Source: SeekingAlpha
2025-06-26 14:50:07 ET
More on Valneva, Bavarian Nordic, etc.
- Bavarian Nordic A/S (BVNKF) Q1 2025 Earnings Call Transcript
- Bavarian Nordic A/S 2025 Q1 - Results - Earnings Call Presentation
- Valneva SE (VALN) Q1 2025 Earnings Call Transcript
- CDC vaccine panel recommends only thimerosal-free flu vaccines
- Former head of anti-vaccine group to make presentation at ACIP meeting
Read the full article on Seeking Alpha
For further details see:
CSL to replace Bavarian Nordic in Valneva’s vaccine deal for Germany
Bavarian Nordic A/S ADR
NASDAQ: BVNRY
BVNRY Trading
2.53% G/L:
$9.58 Last:
7,167 Volume:
$9.58 Open:
BVNRY Latest News
BVNRY Stock Data
$2,396,169,297
231,096,698
N/A
2
N/A
Biotechnology & Life Sciences
Healthcare
DK
Kvistgaard
